Article
Fledgling drugs like infliximab offer more hope than traditional methods
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Suicide Risk Management Crucial in Dermatological Care
Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor
Quoin Receives FDA Clearance for Second Netherton Trial
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
Ascletis Receives FDA Clearance to Advance ASC50, a Novel Oral IL-17 Inhibitor, Into Phase 1 Psoriasis Trial
Cutibacterium acnes Dominates the Post-Laser Skin Microbiome